Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

“There are things that we can do at all stages of our lives deliberately,” says Prof Schott. “It’s never too early to start ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...

Hidden Fat Predicts Alzheimer's 20 Years Ahead of Symptoms ... Study Identifies Potential New Drug for Parkinson's-Related Cognitive Decline, Dementia Nov. 19, 2024 — A recently published ...

Firms developing Alzheimer’s drugs have already seen big peaks and troughs. Biogen shares soared 44% on a single day in November 2020 after news that an experimental drug appeared to be ...

19, 2024 — Phase I clinical trial of a drug was successfully ... brain that are hallmarks of Alzheimer's disease up to 20 years before the earliest symptoms of dementia ...